Abstract
Psychiatric diagnosis has proven far more complicated than anyone believed 50 years ago when the first edition of the Diagnostic and Statistical Manual saw the light of day. Psychiatry has always had a nosology, or classification of diseases, beginning with the rough categories established in the early nineteenth century. Between the late nineteenth and mid-twentieth centuries, psychiatric classification was shaped by individual authorities, in particular by the great German nosologist Emil Kraepelin.
The DSM series of the American Psychiatric Association grew out of a desire to create an American system in line with the International Classification of Diseases series issued by the World Health Organization. In some ways its evolution represents progress towards a genuine medical model of classification. Yet in other respects the series has been hijacked by consensus and horse-trading, becoming a political rather than scientific document. Despite enormous investments of time, thought and academic firepower, the process of establishing a reliable nosology of psychiatric illness continues to elude our grasp.
Keywords
- Bipolar Disorder
- Seasonal Affective Disorder
- York State Psychiatric Institute
- Dissociative Disorder
- Schizotypal Personality Disorder
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Author not identified in accordance with the ground rules of the listserv.
References
American College of Neuropsychopharmacology. In the beginning.... The origin of the American College of Neuropsychopharmacology. Brentwood, TN: ACNP; 1990.
Pinel P. Traité médico-philosophique sur l’aliénation mentale. 2nd ed. Paris: Brosson; 1809.
Heinroth FCA. Lehrbuch der Störungen des Seelenlebens. Leipzig: Vogel; 1818.
Bell LV. On a form of disease resembling some advanced stages of mania and fever, but so contradistinguished from any ordinarily observed or described combination of symptoms, as to render it probable that it may be an overlooked and hitherto unrecorded malady. Am J Insanity. 1849;6(2):97–127, 99.
Delasiauve L. Du diagnostic différentiel de la lypémanie. Ann Méd Psychol. 1851;(3):380–442, 380.
Kraepelin E. Compendium der Psychiatrie. Leipzig: Abel; 1883.
Kraepelin E. Psychiatrie: ein kurzes Lehrbuch für Studierende und Ärzte. 8th ed. Leipzig: Barth; 1909–1915.
Gaupp R. Die Frage der kombinierten Psychosen. Zeits Neurol Psychiatry. 1926;76(1):73–80, 77–8.
Bleuler E, Jung CG. Komplexe und Krankheitsursachen bei Dementia praecox. Zentralbl Nervenheilk Psychiatr. 1908;19:220–7.
Kraepelin E. Psychiatrie: ein kurzes Lehrbuch für Studierende und Ärzte. 6th ed. Leipzig: Barth; 1899.
Kraepelin E. Die Abgrenzung der Paranoia. Allg Zeits Psychiatr. 1894;50:1080–1.
Lewis A. “Endogenous” and “exogenous”: a useful dichotomy? Psychol Med. 1971;1(3):191–6.
Stengel E. Classification of mental disorders. Bull World Health Organ. 1959;21(4–5):601–63.
Menninger WC. Psychiatric nomenclature. J Nerv Ment Dis. 1946;104(2):180–99.
Fink M. Interview. In: Ban TA, editor. An oral history of neuropsychopharmacology: the first fifty years; peer interviews, vol. 9. Brentwood, TN: ACNP; 2011. p. 76.
World Health Organization. Manual of the international statistical classification of diseases, injuries and causes of death. 6th revision [later known as ICD-6] 2 volumes. Geneva: WHO; 1948–49.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: APA; 1952.
Klein DF, Fink M. Psychiatric reaction patterns to imipramine. Am J Psychiatry. 1962; 119(5):432–8.
Müller C. Lexikon der Psychiatrie. Berlin: Springer; 1973. p. 409–15.
Lambert P. Discussion. In: Bradley PB, Deniker P, Raduoco-Thomas C, editors. Neuro-psychopharmacology: proceedings of the first international congress of neuro-psychopharmacology, Rome, September 1958. Amsterdam: Elsevier; 1959. p. 212.
American Psychiatric Association. DSM-II: diagnostic and statistical manual of mental disorders. 2nd ed. Washington, DC: APA; 1968.
Kendell RE, Cooper JE, Gourlay AJ, Copeland JRM, Sharpe L, Gurland BJ. Diagnostic criteria of American and British psychiatrists. Arch Gen Psychiatry. 1971;25(2):123–30.
Frank J. Discussion comment. In: Zubin J, Freyhan F, editors. Disorders of mood. Baltimore: Johns Hopkins Press; 1972. p. 30.
Katz M, Williams TA, Shield JA. Recent advances in the psychobiology of the depressive illnesses. Proceedings of a workshop hosted by the College of William and Mary in Virginia, April 30 through May 2, 1969. National Institute of Mental Health, Division of Extramural Research Programs, Clinical Research branch. Washington, DC: Superintendent of Documents, US Government Printing Office; 1972.
Weissman M. Interview. Gerald Klerman and psychopharmacology. In: Healy D, editor. The psychopharmacologists, vol. 2. London: Altman; 1998. p. 521–42, 530.
Clayton PJ. Interview. In: Ban TA, editor. An oral history of neuropsychopharmacology: the first fifty years; peer interviews, vol. 7. Brentwood, TN: ACNP; 2011. p. 99.
Henn FA. Interview. In: Ban TA, editor. An oral history of neuropsychopharmacology: the first fifty years; peer interviews, vol. 8. Brentwood, TN: ACNP; 2011. p. 154.
Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Muñoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972;26(1):57–63.
Katz MM. Interview. In: Ban TA, editor. An oral history of neuropsychopharmacology: the first fifty years; peer interviews, vol. 9. Brentwood, TN: ACNP; 2011. p. 200.
Shorter E. Bipolar disorder in historical perspective. In: Parker G, editor. Bipolar II disorder: modeling, measuring and managing. 2nd ed. Cambridge, UK: Cambridge University Press; 2012. p. 1–9.
Spitzer RL, Endicott J, Robins E, Kuriansky J, Gurland B. Preliminary report of the reliability of research diagnostic criteria applied to psychiatric case records. In: Sudilovsky A, Gershon S, Beer B, editors. Predictability in psychopharmacology: preclinical and clinical correlations. New York: Raven; 1975. p. 1–47.
Shorter E. How everyone became depressed: the rise and fall of the nervous breakdown. New York: Oxford University Press; 2013.
Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Arch Gen Psychiatry. 1978;35(6):773–82.
Klein DF. Interview. In: Ban TA, editor. An oral history of neuropsychopharmacology: the first fifty years; peer interviews, vol. 9. Brentwood, TN: ACNP; 2011. p. 214.
Klerman GL, Endicott J, Spitzer R, Hirschfeld RMA. Neurotic depressions: a systematic analysis of multiple criteria and meanings. Am J Psychiatry. 1979;136(1):57–61.
Rudorfer MV, Clayton PJ. Depression, dementia and dexamethasone suppression [letter]. Am J Psychiatry. 1981;138(5):701.
Healy D, editor. The psychopharmacologists, vol. 2. London: Altman; 1998. p. 555.
Taylor MA, Vaidya NA. Descriptive psychopathology: the signs and symptoms of behavioral disorders. Cambridge, UK: Cambridge University Press; 2009.
McHugh PR, Slavney PR. Mental illness—comprehensive evaluation or checklist? N Engl J Med. 2012;366(20):1853–5, 1854.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (third edition—revised): DSM-III-R. Washington, DC: APA; 1987.
Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, et al. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72–80.
Frances A. Opening Pandora’s box: the 19 worst suggestions for DSM-5. Psychiatric Times, 11 Feb 2010.
Frances A, Cooper AM. Descriptive and dynamic psychiatry: a perspective on DSM-III. Am J Psychiatry. 1981;138(9):1198–202.
Frances A. Dr Frances responds to Dr Carpenter: a sharp difference of opinion. Psychiatric Times, 9 Jul 2009.
Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160(1):4–12, 5, 11.
Clayton PJ, Guze SB, Cloninger CR, Martin RL. Unipolar depression: diagnostic inconsistency and its implications. J Affect Disord. 1992;26(2):111–6.
Taylor MA, Fink M. Melancholia: the diagnosis, pathophysiology, and treatment of depressive illness. Cambridge, UK: Cambridge University Press; 2006.
Fink M, Taylor MA. Catatonia: a clinician’s guide to diagnosis and treatment. Cambridge, UK: Cambridge University Press; 2003.
Craddock N, Owen MJ. Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry. 2007;6(2):84–91.
Carroll B. Comment on: as precisely as possible. In: 1 Boring old man [Internet]. http://1boringoldman.com/index.php/2011/12/05/as-precisely-as-possible/. Accessed 5 Dec 2011.
Parker G, Hadzi-Pavlovic D, Wilhelm K, Hickie I, Brodaty H, Boyce P, et al. Defining melancholia: properties of a refined sign-based measure. Br J Psychiatry. 1994;164(3):316–26.
Lewis AJ. Melancholia: a clinical survey of depressive states. J Ment Sci. 1934;80(329):277–378, 280.
Spitzer R. Interview. In: Healy D, editor. The psychopharmacologists, vol. 3. London: Altman; 1998. p. 427.
Acknowledgments
For comments on an earlier version, I am grateful to Bernard Carroll and Max Fink.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shorter, E. (2013). The History of DSM. In: Paris, J., Phillips, J. (eds) Making the DSM-5. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6504-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6504-1_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6503-4
Online ISBN: 978-1-4614-6504-1
eBook Packages: MedicineMedicine (R0)